Systematic review of metformin monotherapy and dual therapy with sodium glucose co-transporter 2 inhibitor (SGLT-2) in treatment of type 2 diabetes mellitus.
Published Oct 1, 2017 · Nagashekhara Molugulu, Lai Shu Yee, Yew Tze Ye
Diabetes research and clinical practice
24
Citations
1
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayCombined therapy of SGLT2 inhibitor and metformin is more effective in HbA1c reduction and weight reduction compared to monotherapy using metformin alone for type 2 diabetes management.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.